Precision Medicine

On 5 October 2026, the SHAIPED Stakeholder Forum brought together various stakeholders. Among the contributors was SYNTHIA Partner Ahmed Youssef Ali from Johnson & Johnson Innovative Medicine.

On 20–21 October 2026, SYNTHIA was represented at the Innovative Health Initiative (IHI) Forum 2026 in Brussels, Belgium.

Two years into SYNTHIA, the project is entering an important new phase. With methods being developed, data being prepared, use cases progressing and the SYNTHIA Platform taking shape.

On World Cancer Research Day, SYNTHIA joins the global community in highlighting the importance of continued research, collaboration and innovation to advance cancer prevention, diagnosis, treatment and care.

Insight featuring Stella (Styliani-Christina) Fragkouli from CERTH.

On World Alzheimer’s Day, observed during World Alzheimer’s Month, SYNTHIA joins the global community in raising awareness of Alzheimer’s disease.

EU Cancer Mission marks five years. SYNTHIA is contributing by exploring how synthetic data can help overcome some of the data challenges that continue to limit cancer research and innovation.

During Blood Cancer Awareness Month, SYNTHIA joins the global community in raising awareness of blood cancers and highlighting the importance of continued research and innovation.

On World Breast Cancer Research Day, SYNTHIA joins the global community in recognizing the importance of continued research and innovation to improve breast cancer detection, treatment and outcomes.

Insight featuring Gianluca Asti from Humanitas.

SYNTHIA is inviting citizens across Europe to take part in an important new survey exploring public perspectives on synthetic data in healthcare.

SYNTHIA hosted a high-level panel discussion at the ICT&health World Conference 2026 in Maastricht, The Netherlands.

Health Technology Assessment (HTA) and regulatory engagement are essential.